Presentations by drug application sponsors could have a lot more time to sink in during a virtual US Food and Drug Administration advisory committee meeting than at the in-person variety.
Among the ideas that could be piloted are not only pre-recording sponsor presentations and other sessions, but also releasing the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?